The expression levels of CD28 and CD40LG are tightly regulated in normal T cells, as abnormal activation or overexpression of them lead to many types of T-cell malignancies including ATLL and T-cell lymphomas [22–28]. This evidence concerns the gene CD40LG and T-cell non-Hodgkin lymphoma.